RecruitingNCT01163578

Biomarkers in Transplant Recipients to Improve Outcomes

Study of Biomarkers in Solid Organ and Bone Marrow Transplant Recipients to Better Treat Rejection


Sponsor

University of Pittsburgh

Enrollment

1,200 participants

Start Date

Mar 1, 2005

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with bone marrow transplantation and solid-organ transplantation. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Children's Hospital of Pittsburgh of UPMC

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01163578


Related Trials